AllianceBernstein’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.2M | Buy |
398,005
+4,030
| +1% | +$209K | 0.01% | 912 |
|
|
2026
Q1 | $11.6M | Sell |
393,975
-11,231
| -3% | -$524K | ﹤0.01% | 1134 |
|
|
2025
Q4 | $11.9M | Sell |
405,206
-9,452
| -2% | -$257K | ﹤0.01% | 1161 |
|
|
2025
Q3 | $10.7M | Sell |
414,658
-13,006
| -3% | -$363K | ﹤0.01% | 1182 |
|
|
2025
Q2 | $11.8M | Buy |
427,664
+73,896
| +21% | +$1.95M | ﹤0.01% | 1105 |
|
|
2025
Q1 | $10M | Buy |
353,768
+22,329
| +7% | +$792K | ﹤0.01% | 1158 |
|
|
2024
Q4 | $13.8M | Buy |
331,439
+1,705
| +0.5% | +$81.5K | ﹤0.01% | 1037 |
|
|
2024
Q3 | $22M | Sell |
329,734
-75,971
| -19% | -$6.98M | 0.01% | 874 |
|
|
2024
Q2 | $48.2M | Buy |
405,705
+20,343
| +5% | +$2.57M | 0.02% | 603 |
|
|
2024
Q1 | $41.1M | Sell |
385,362
-31,264
| -8% | -$3.15M | 0.01% | 659 |
|
|
2023
Q4 | $41.4M | Sell |
416,626
-28,598
| -6% | -$2.41M | 0.02% | 643 |
|
|
2023
Q3 | $46M | Buy |
445,224
+47,962
| +12% | +$5.35M | 0.02% | 584 |
|
|
2023
Q2 | $48.3M | Sell |
397,262
-1,580
| -0.4% | -$211K | 0.02% | 583 |
|
|
2023
Q1 | $61.3M | Sell |
398,842
-91,916
| -19% | -$15.2M | 0.03% | 508 |
|
|
2022
Q4 | $88.1M | Sell |
490,758
-13,984
| -3% | -$2.29M | 0.04% | 413 |
|
|
2022
Q3 | $59.7M | Sell |
504,742
-5,657
| -1% | -$858K | 0.03% | 494 |
|
|
2022
Q2 | $72.9M | Buy |
510,399
+38,595
| +8% | +$5.52M | 0.03% | 453 |
|
|
2022
Q1 | $81.3M | Sell |
471,804
-35,100
| -7% | -$5.91M | 0.03% | 460 |
|
|
2021
Q4 | $129M | Sell |
506,904
-25,884
| -5% | -$7.57M | 0.05% | 369 |
|
|
2021
Q3 | $205M | Buy |
532,788
+350,317
| +192% | +$129M | 0.08% | 224 |
|
|
2021
Q2 | $42.9M | Buy |
182,471
+15,755
| +9% | +$2.82M | 0.02% | 662 |
|
|
2021
Q1 | $21.8M | Buy |
166,716
+6,463
| +4% | +$937K | 0.01% | 899 |
|
|
2020
Q4 | $16.7M | Sell |
160,253
-39
| -0% | -$3.95K | 0.01% | 923 |
|
|
2020
Q3 | $11.3M | Buy |
160,292
+11,270
| +8% | +$786K | 0.01% | 988 |
|
|
2020
Q2 | $9.57M | Buy |
149,022
+30,701
| +26% | +$1.68M | 0.01% | 1021 |
|
|
2020
Q1 | $3.54M | Buy |
118,321
+20,860
| +21% | +$480K | ﹤0.01% | 1344 |
|
|
2019
Q4 | $1.91M | Buy |
97,461
+37,040
| +61% | +$657K | ﹤0.01% | 1995 |
|
|
2019
Q3 | $962K | Buy |
60,421
+6,664
| +12% | +$98.4K | ﹤0.01% | 2268 |
|
|
2019
Q2 | $787K | Buy |
53,757
+35,030
| +187% | +$752K | ﹤0.01% | 2414 |
|
|
2019
Q1 | $381K | Buy |
+18,727
| New | +$348K | ﹤0.01% | 2644 |
|
Other funds holding MRNA
TP
AllianceBernstein's MRNA Position: Q2 2026 in Review
AllianceBernstein increased its Moderna (MRNA) stake by 1% in Q2 2026, buying an estimated $209K and bringing the position to 398,005 shares worth $20.2M. The position accounts for 0.01% of the portfolio, ranked #912.
AllianceBernstein first reported a position in MRNA in Q1 2019 and has held it in 30 quarters since. The position peaked at $205M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- AllianceBernstein held 398,005 shares of Moderna worth $20.2M as of Q2 2026.
- AllianceBernstein bought 4,030 Moderna shares in Q2 2026, an estimated $209K.
- Moderna made up 0.01% of AllianceBernstein's portfolio in Q2 2026, its #912 holding.
- AllianceBernstein first reported a position in Moderna in Q1 2019 and has held it in 30 quarters since.
- AllianceBernstein's Moderna position peaked at $205M in Q3 2021.
- 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.